Myc-driven blood cancer cells, including AML cells HL60 and Kasumi-1, ALL cells Jurkat, and multiple myeloma cells RPMI8226 and U266, were also susceptible to 1 with EC50s of 3.3-9.7 μM. The gene discussed is MYC; the disease is hematopoietic and lymphoid system neoplasm.